Redcare Pharmacy N.V.: Change in the Managing Board; Peter Schmid von Linstow to become Chief Executive Officer.
Published on 08/28/2026 at 11:12 | dgap, AD HOC NEWS| EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Personnel decisions / Executive Board 28-Aug-2026 / 11:12 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Sevenum, August 28, 2026: Redcare Pharmacy's Supervisory Board has designated Peter Schmid von Linstow as member of the Managing Board and Chief Executive Officer, effective October 1, 2026. Peter Schmid von Linstow, currently Deputy Chairman of the Supervisory Board, succeeds Olaf Heinrich, who has decided to step down after three successful years as CEO. Olaf Heinrich will remain available to the company in an advisory capacity. The appointment is on the agenda of an Extraordinary General Meeting on October 14, 2026, for consultation. Contact: Irina Zhurba Director Investor Relations investors@redcare-pharmacy.com End of Inside Information 28-Aug-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| LEI Code: | 529900JK6UXHY1YKZ082 |
| EQS News ID: | 2390388 |
| End of Announcement | EQS News Service |
| |
2390388 28-Aug-2026 CET/CEST
en | NL0012044747 | REDCARE PHARMACY N.V. | boerse | 70013378 |
